CSB 4.04 (2) (gb) The drug dosage units.
(gd) The partial fill indicator.
Section 2. CSB 4.09 (1) (c) and (d) are created to read:
CSB 4.09 (1) (c) Scientific research purposes if all of the following requirements are met:
1.
The patient is a direct patient of the healthcare professional.2.
The healthcare professional has obtained informed consent from the patient to access monitored prescription drug history reports for scientific research purposes.(d) Purposes of conducting an overdose fatality review.
Section 3. CSB 4.093 (2m) is created to read:
CSB 4.093 (2m) Department staff who are charged with investigating dispensers, dispenser delegates, pharmacists, pharmacist delegates, practitioners, and practitioner delegates may access the audit trails related to s. CSB 4.12 (3) (f) and (g). Section 4. CSB 4.11 (9) is amended to read:
CSB 4.11 (9) The board may disclose PDMP data without personally identifiable information that could be reasonably used to identify any patient, healthcare professional, practitioner delegate, pharmacist delegate, or dispenser for public health and scientific research purposes. The board may require evidence of institutional review board approval.
Section 5. EFFECTIVE DATE. The rules adopted in this order shall take effect on the first day of the month following publication in the Wisconsin Administrative Register, pursuant to s. 227.22 (2) (intro.), Stats. ---------------------------------------------------------------------------------------------------------------------
(END OF TEXT OF RULE)
---------------------------------------------------------------------------------------------------------------------
Dated _July 10, 2020_ Agency 
Chair
Controlled Substances Board
